{"id":"W4323044887","doi":"10.1002/jvc2.100","title":"Efficacy of dupilumab in moderate and severe atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"JEADV Clinical Practice","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"LEO Pharma; Galderma; Incyte; Mitsubishi Tanabe Pharma Corporation; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi; Valeant Pharmaceuticals International; Pfizer; Kyowa Hakko Kirin; Eli Lilly and Company","keywords":"Dupilumab; Atopic dermatitis; Medicine; Placebo; Concomitant; Eczema Area and Severity Index; Internal medicine; Severity of illness; SCORAD; Randomized controlled trial; Dermatology; Gastroenterology; Dermatology Life Quality Index; Pathology; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0005535756,0.00008099611,0.0003622509,0.00007318355,0.0000310566,0.000007725762,0.00005176752,0.0001471335,0.00006003978],"category_scores_gemma":[0.01218037,0.00007248552,0.00006878709,0.0002219434,0.0001347035,0.0002019126,0.00006193163,0.000322211,0.0001801226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007475095,"about_ca_system_score_gemma":0.00009568133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002139904,"about_ca_topic_score_gemma":0.00000736292,"domain_scores_codex":[0.9986708,0.0002623993,0.0005579962,0.0002055043,0.0001465414,0.0001567607],"domain_scores_gemma":[0.994257,0.005184437,0.0001459617,0.0002247362,0.0000699727,0.0001179005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00283947,0.002045159,0.8679087,0.000566934,0.0002911148,0.00343777,0.0005121009,0.00004982889,0.00001274011,0.001273778,0.07029125,0.05077113],"study_design_scores_gemma":[0.004259064,0.00008323931,0.9718815,0.0001064625,0.0001364374,0.0002814155,0.0001621258,0.001144298,0.00002595037,0.0007941806,0.02104421,0.00008109502],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761062,0.0005197815,0.00001593,0.01305482,0.000153499,0.0002180815,0.000004589299,0.00005890206,0.009868221],"genre_scores_gemma":[0.9947822,0.0008820451,0.0005521131,0.003150559,0.00005352338,0.000007715248,0.00001467002,0.000009723196,0.0005474612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1039728,"threshold_uncertainty_score":0.9961404,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05785822509584972,"score_gpt":0.4206879285004587,"score_spread":0.362829703404609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}